Pre-order Enquiry
Request Free Sample
Global Dermatology OTC Medications Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18738827 | Publishing Date : 13-Jul-2021 | No. of pages : 133
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Dermatology OTC Medications Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Dermatology OTC Medications Market Overview1.1 Dermatology OTC Medications Product Overview
1.2 Dermatology OTC Medications Market Segment by Type
1.2.1 External Use
1.2.2 Oral
1.3 Global Dermatology OTC Medications Market Size by Type
1.3.1 Global Dermatology OTC Medications Market Size Overview by Type (2016-2027)
1.3.2 Global Dermatology OTC Medications Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Dermatology OTC Medications Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Dermatology OTC Medications Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Dermatology OTC Medications Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Dermatology OTC Medications Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Dermatology OTC Medications Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dermatology OTC Medications Sales Breakdown by Type (2016-2021)
1.4.2 Europe Dermatology OTC Medications Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Dermatology OTC Medications Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Type (2016-2021)
2 Global Dermatology OTC Medications Market Competition by Company
2.1 Global Top Players by Dermatology OTC Medications Sales (2016-2021)
2.2 Global Top Players by Dermatology OTC Medications Revenue (2016-2021)
2.3 Global Top Players Dermatology OTC Medications Price (2016-2021)
2.4 Global Top Manufacturers Dermatology OTC Medications Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dermatology OTC Medications Market Competitive Situation and Trends
2.5.1 Dermatology OTC Medications Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Dermatology OTC Medications Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2020)
2.7 Date of Key Manufacturers Enter into Dermatology OTC Medications Market
2.8 Key Manufacturers Dermatology OTC Medications Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dermatology OTC Medications Status and Outlook by Region
3.1 Global Dermatology OTC Medications Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Dermatology OTC Medications Historic Market Size by Region
3.2.1 Global Dermatology OTC Medications Sales in Volume by Region (2016-2021)
3.2.2 Global Dermatology OTC Medications Sales in Value by Region (2016-2021)
3.2.3 Global Dermatology OTC Medications Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Dermatology OTC Medications Forecasted Market Size by Region
3.3.1 Global Dermatology OTC Medications Sales in Volume by Region (2022-2027)
3.3.2 Global Dermatology OTC Medications Sales in Value by Region (2022-2027)
3.3.3 Global Dermatology OTC Medications Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Dermatology OTC Medications by Application
4.1 Dermatology OTC Medications Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 Other
4.2 Global Dermatology OTC Medications Market Size by Application
4.2.1 Global Dermatology OTC Medications Market Size Overview by Application (2016-2027)
4.2.2 Global Dermatology OTC Medications Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Dermatology OTC Medications Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Dermatology OTC Medications Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Dermatology OTC Medications Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Dermatology OTC Medications Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Dermatology OTC Medications Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Dermatology OTC Medications Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dermatology OTC Medications Sales Breakdown by Application (2016-2021)
4.3.2 Europe Dermatology OTC Medications Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Dermatology OTC Medications Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Application (2016-2021)
5 North America Dermatology OTC Medications by Country
5.1 North America Dermatology OTC Medications Historic Market Size by Country
5.1.1 North America Dermatology OTC Medications Sales in Volume by Country (2016-2021)
5.1.2 North America Dermatology OTC Medications Sales in Value by Country (2016-2021)
5.2 North America Dermatology OTC Medications Forecasted Market Size by Country
5.2.1 North America Dermatology OTC Medications Sales in Volume by Country (2022-2027)
5.2.2 North America Dermatology OTC Medications Sales in Value by Country (2022-2027)
6 Europe Dermatology OTC Medications by Country
6.1 Europe Dermatology OTC Medications Historic Market Size by Country
6.1.1 Europe Dermatology OTC Medications Sales in Volume by Country (2016-2021)
6.1.2 Europe Dermatology OTC Medications Sales in Value by Country (2016-2021)
6.2 Europe Dermatology OTC Medications Forecasted Market Size by Country
6.2.1 Europe Dermatology OTC Medications Sales in Volume by Country (2022-2027)
6.2.2 Europe Dermatology OTC Medications Sales in Value by Country (2022-2027)
7 Asia-Pacific Dermatology OTC Medications by Region
7.1 Asia-Pacific Dermatology OTC Medications Historic Market Size by Region
7.1.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Dermatology OTC Medications Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Dermatology OTC Medications Forecasted Market Size by Region
7.2.1 Asia-Pacific Dermatology OTC Medications Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Dermatology OTC Medications Sales in Value by Region (2022-2027)
8 Latin America Dermatology OTC Medications by Country
8.1 Latin America Dermatology OTC Medications Historic Market Size by Country
8.1.1 Latin America Dermatology OTC Medications Sales in Volume by Country (2016-2021)
8.1.2 Latin America Dermatology OTC Medications Sales in Value by Country (2016-2021)
8.2 Latin America Dermatology OTC Medications Forecasted Market Size by Country
8.2.1 Latin America Dermatology OTC Medications Sales in Volume by Country (2022-2027)
8.2.2 Latin America Dermatology OTC Medications Sales in Value by Country (2022-2027)
9 Middle East and Africa Dermatology OTC Medications by Country
9.1 Middle East and Africa Dermatology OTC Medications Historic Market Size by Country
9.1.1 Middle East and Africa Dermatology OTC Medications Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Dermatology OTC Medications Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Dermatology OTC Medications Forecasted Market Size by Country
9.2.1 Middle East and Africa Dermatology OTC Medications Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Dermatology OTC Medications Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Dermatology OTC Medications Business
10.1 Bayer
10.1.1 Bayer Corporation Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Bayer Dermatology OTC Medications Products Offered
10.1.5 Bayer Recent Development
10.2 GSK
10.2.1 GSK Corporation Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.2.4 GSK Dermatology OTC Medications Products Offered
10.2.5 GSK Recent Development
10.3 Teva
10.3.1 Teva Corporation Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Teva Dermatology OTC Medications Products Offered
10.3.5 Teva Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Corporation Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Novartis
10.5.1 Novartis Corporation Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Novartis Dermatology OTC Medications Products Offered
10.5.5 Novartis Recent Development
10.6 Mylan
10.6.1 Mylan Corporation Information
10.6.2 Mylan Introduction and Business Overview
10.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Mylan Dermatology OTC Medications Products Offered
10.6.5 Mylan Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Corporation Information
10.7.2 Sun Pharmaceutical Introduction and Business Overview
10.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered
10.7.5 Sun Pharmaceutical Recent Development
10.8 Aurobindo
10.8.1 Aurobindo Corporation Information
10.8.2 Aurobindo Introduction and Business Overview
10.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Aurobindo Dermatology OTC Medications Products Offered
10.8.5 Aurobindo Recent Development
10.9 Galderma
10.9.1 Galderma Corporation Information
10.9.2 Galderma Introduction and Business Overview
10.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Galderma Dermatology OTC Medications Products Offered
10.9.5 Galderma Recent Development
10.10 CR SANJIU
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Dermatology OTC Medications Product Category, Application and Specification
10.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 CR SANJIU Recent Development
10.11 Dr. Reddy's
10.11.1 Dr. Reddy's Corporation Information
10.11.2 Dr. Reddy's Introduction and Business Overview
10.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Dr. Reddy's Dermatology OTC Medications Products Offered
10.11.5 Dr. Reddy's Recent Development
10.12 Lupin
10.12.1 Lupin Corporation Information
10.12.2 Lupin Introduction and Business Overview
10.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Lupin Dermatology OTC Medications Products Offered
10.12.5 Lupin Recent Development
10.13 Bausch Health
10.13.1 Bausch Health Corporation Information
10.13.2 Bausch Health Introduction and Business Overview
10.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Bausch Health Dermatology OTC Medications Products Offered
10.13.5 Bausch Health Recent Development
10.14 Cipla
10.14.1 Cipla Corporation Information
10.14.2 Cipla Introduction and Business Overview
10.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Cipla Dermatology OTC Medications Products Offered
10.14.5 Cipla Recent Development
10.15 Qilu Pharmaceutical
10.15.1 Qilu Pharmaceutical Corporation Information
10.15.2 Qilu Pharmaceutical Introduction and Business Overview
10.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Qilu Pharmaceutical Dermatology OTC Medications Products Offered
10.15.5 Qilu Pharmaceutical Recent Development
10.16 Almirall
10.16.1 Almirall Corporation Information
10.16.2 Almirall Introduction and Business Overview
10.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Almirall Dermatology OTC Medications Products Offered
10.16.5 Almirall Recent Development
10.17 Lingrui
10.17.1 Lingrui Corporation Information
10.17.2 Lingrui Introduction and Business Overview
10.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Lingrui Dermatology OTC Medications Products Offered
10.17.5 Lingrui Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dermatology OTC Medications Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dermatology OTC Medications Industrial Chain Analysis
11.4 Dermatology OTC Medications Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dermatology OTC Medications Distributors
12.3 Dermatology OTC Medications Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Dermatology OTC Medications Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of External Use
Table 2. Major Company of Oral
Table 3. Global Dermatology OTC Medications Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 4. Global Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 5. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2016-2021)
Table 6. Global Dermatology OTC Medications Sales by Type (2016-2021) & (US& Million)
Table 7. Global Dermatology OTC Medications Market Share in Value by Type (2016-2021)
Table 8. Global Dermatology OTC Medications Price by Type (2016-2021) & (USD/Unit)
Table 9. Global Dermatology OTC Medications Sales by Type (2022-2027) & (M Units)
Table 10. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2022-2027)
Table 11. Global Dermatology OTC Medications Sales by Type (2022-2027) & (US$ Million)
Table 12. Global Dermatology OTC Medications Sales Market Share in Value by Type (2022-2027)
Table 13. Global Dermatology OTC Medications Price by Type (2022-2027) & (USD/Unit)
Table 14. North America Dermatology OTC Medications Sales by Type (2016-2021) & (M Units)
Table 15. North America Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million)
Table 16. Europe Dermatology OTC Medications Sales (M Units) by Type (2016-2021)
Table 17. Europe Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million)
Table 18. Asia-Pacific Dermatology OTC Medications Sales (M Units) by Type (2016-2021)
Table 19. Asia-Pacific Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million)
Table 20. Latin America Dermatology OTC Medications Sales (M Units) by Type (2016-2021)
Table 21. Latin America Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million)
Table 22. Middle East and Africa Dermatology OTC Medications Sales (M Units) by Type (2016-2021)
Table 23. Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2021) & (US$ Million)
Table 24. Global Dermatology OTC Medications Sales by Company (2016-2021) & (M Units)
Table 25. Global Dermatology OTC Medications Sales Share by Company (2016-2021)
Table 26. Global Dermatology OTC Medications Revenue by Company (2016-2021) & (US$ Million)
Table 27. Global Dermatology OTC Medications Revenue Share by Company (2016-2021)
Table 28. Global Market Dermatology OTC Medications Price by Company (2016-2021) & (USD/Unit)
Table 29. Global Dermatology OTC Medications Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2020
Table 32. Date of Key Manufacturers Enter into Dermatology OTC Medications Market
Table 33. Key Manufacturers Dermatology OTC Medications Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Dermatology OTC Medications Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 36. Global Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
Table 37. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2016-2021)
Table 38. Global Dermatology OTC Medications Sales by Region (2016-2021) & (US$ Million)
Table 39. Global Dermatology OTC Medications Sales Market Share in Value by Region (2016-2021)
Table 40. Global Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 41. Global Dermatology OTC Medications Sales by Region (2022-2027) & (M Units)
Table 42. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2022-2027)
Table 43. Global Dermatology OTC Medications Sales by Region (2022-2027) & (US$ Million)
Table 44. Global Dermatology OTC Medications Sales Market Share in Value by Region (2022-2027)
Table 45. Global Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027)
Table 46. Global Dermatology OTC Medications Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 47. Global Dermatology OTC Medications Sales by Application (2016-2021) & (M Units)
Table 48. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2016-2021)
Table 49. Global Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million)
Table 50. Global Dermatology OTC Medications Sales Market Share in Value by Application (2016-2021)
Table 51. Global Dermatology OTC Medications Price by Application (2016-2021) & (USD/Unit)
Table 52. Global Dermatology OTC Medications Sales by Application (2022-2027) & (M Units)
Table 53. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2022-2027)
Table 54. Global Dermatology OTC Medications Sales by Application (2022-2027) & (US$ Million)
Table 55. Global Dermatology OTC Medications Sales Market Share in Value by Application (2022-2027)
Table 56. Global Dermatology OTC Medications Price by Application (2022-2027) & (USD/Unit)
Table 57. North America Dermatology OTC Medications Sales by Application (2016-2021) (M Units)
Table 58. North America Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million)
Table 59. North America Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Table 60. Europe Dermatology OTC Medications Sales by Application (2016-2021) (M Units)
Table 61. Europe Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million)
Table 62. Europe Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Table 63. Asia-Pacific Dermatology OTC Medications Sales by Application (2016-2021) (M Units)
Table 64. Asia-Pacific Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million)
Table 65. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Table 66. Latin America Dermatology OTC Medications Sales by Application (2016-2021) (M Units)
Table 67. Latin America Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million)
Table 68. Latin America Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Table 69. Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2021) (M Units)
Table 70. Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2021) & (US$ Million)
Table 71. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Table 72. North America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 73. North America Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021)
Table 74. North America Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million)
Table 75. North America Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021)
Table 76. North America Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
Table 77. North America Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027)
Table 78. North America Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million)
Table 79. North America Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027)
Table 80. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 81. Europe Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021)
Table 82. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million)
Table 83. Europe Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021)
Table 84. Europe Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
Table 85. Europe Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027)
Table 86. Europe Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million)
Table 87. Europe Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027)
Table 88. Asia-Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (M Units)
Table 89. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Region (2016-2021)
Table 90. Asia-Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (US$ Million)
Table 91. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Region (2016-2021)
Table 92. Asia-Pacific Dermatology OTC Medications Sales by Region (2022-2027) & (M Units)
Table 93. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Region (2022-2027)
Table 94. Asia-Pacific Dermatology OTC Medications Sales by Region (2022-2027) & (US$ Million)
Table 95. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Region (2022-2027)
Table 96. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 97. Latin America Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021)
Table 98. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million)
Table 99. Latin America Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021)
Table 100. Latin America Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
Table 101. Latin America Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027)
Table 102. Latin America Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million)
Table 103. Latin America Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027)
Table 104. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (M Units)
Table 105. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Country (2016-2021)
Table 106. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Country (2016-2021)
Table 108. Middle East and Africa Dermatology OTC Medications Sales by Country (2022-2027) & (M Units)
Table 109. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Country (2022-2027)
Table 110. Middle East and Africa Dermatology OTC Medications Sales by Country (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Country (2022-2027)
Table 112. Bayer Corporation Information
Table 113. Bayer Introduction and Business Overview
Table 114. Bayer Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Bayer Dermatology OTC Medications Product
Table 116. Bayer Recent Development
Table 117. GSK Corporation Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. GSK Dermatology OTC Medications Product
Table 121. GSK Recent Development
Table 122. Teva Corporation Information
Table 123. Teva Introduction and Business Overview
Table 124. Teva Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Teva Dermatology OTC Medications Product
Table 126. Teva Recent Development
Table 127. Johnson & Johnson Corporation Information
Table 128. Johnson & Johnson Introduction and Business Overview
Table 129. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Johnson & Johnson Dermatology OTC Medications Product
Table 131. Johnson & Johnson Recent Development
Table 132. Novartis Corporation Information
Table 133. Novartis Introduction and Business Overview
Table 134. Novartis Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Novartis Dermatology OTC Medications Product
Table 136. Novartis Recent Development
Table 137. Mylan Corporation Information
Table 138. Mylan Introduction and Business Overview
Table 139. Mylan Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Mylan Dermatology OTC Medications Product
Table 141. Mylan Recent Development
Table 142. Sun Pharmaceutical Corporation Information
Table 143. Sun Pharmaceutical Introduction and Business Overview
Table 144. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Sun Pharmaceutical Dermatology OTC Medications Product
Table 146. Sun Pharmaceutical Recent Development
Table 147. Aurobindo Corporation Information
Table 148. Aurobindo Introduction and Business Overview
Table 149. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Aurobindo Dermatology OTC Medications Product
Table 151. Aurobindo Recent Development
Table 152. Galderma Corporation Information
Table 153. Galderma Introduction and Business Overview
Table 154. Galderma Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Galderma Dermatology OTC Medications Product
Table 156. Galderma Recent Development
Table 157. CR SANJIU Corporation Information
Table 158. CR SANJIU Introduction and Business Overview
Table 159. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. CR SANJIU Dermatology OTC Medications Product
Table 161. CR SANJIU Recent Development
Table 162. Dr. Reddy's Corporation Information
Table 163. Dr. Reddy's Introduction and Business Overview
Table 164. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 165. Dr. Reddy's Dermatology OTC Medications Product
Table 166. Dr. Reddy's Recent Development
Table 167. Lupin Corporation Information
Table 168. Lupin Introduction and Business Overview
Table 169. Lupin Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 170. Lupin Dermatology OTC Medications Product
Table 171. Lupin Recent Development
Table 172. Bausch Health Corporation Information
Table 173. Bausch Health Introduction and Business Overview
Table 174. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 175. Bausch Health Dermatology OTC Medications Product
Table 176. Bausch Health Recent Development
Table 177. Cipla Corporation Information
Table 178. Cipla Introduction and Business Overview
Table 179. Cipla Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 180. Cipla Dermatology OTC Medications Product
Table 181. Cipla Recent Development
Table 182. Qilu Pharmaceutical Corporation Information
Table 183. Qilu Pharmaceutical Introduction and Business Overview
Table 184. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 185. Qilu Pharmaceutical Dermatology OTC Medications Product
Table 186. Qilu Pharmaceutical Recent Development
Table 187. Almirall Corporation Information
Table 188. Almirall Introduction and Business Overview
Table 189. Almirall Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 190. Almirall Dermatology OTC Medications Product
Table 191. Almirall Recent Development
Table 192. Lingrui Corporation Information
Table 193. Lingrui Introduction and Business Overview
Table 194. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 195. Lingrui Dermatology OTC Medications Product
Table 196. Lingrui Recent Development
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Dermatology OTC Medications Market Trends
Table 200. Dermatology OTC Medications Market Drivers
Table 201. Dermatology OTC Medications Market Challenges
Table 202. Dermatology OTC Medications Market Restraints
Table 203. Dermatology OTC Medications Distributors List
Table 204. Dermatology OTC Medications Downstream Customers
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology OTC Medications Product Picture
Figure 2. Global Dermatology OTC Medications Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Dermatology OTC Medications Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Dermatology OTC Medications Sales Status and Outlook (2016-2027) & (M Units)
Figure 5. Product Picture of External Use
Figure 6. Global External Use Sales YoY Growth (2016-2021) & (M Units)
Figure 7. Product Picture of Oral
Figure 8. Global Oral Sales YoY Growth (2016-2021) & (M Units)
Figure 9. Global Dermatology OTC Medications Sales by Type (2016-2027) & (US$ Million)
Figure 10. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2016-2021)
Figure 11. Global Dermatology OTC Medications Sales Market Share in Value by Type (2016-2021)
Figure 12. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2022-2027)
Figure 13. Global Dermatology OTC Medications Sales Market Share in Value by Type (2022-2027)
Figure 14. North America Dermatology OTC Medications Sales Market Share in Volume by Type in 2020
Figure 15. North America Dermatology OTC Medications Sales Market Share in Value by Type in 2020
Figure 16. Europe Dermatology OTC Medications Sales Market Share in Volume by Type in 2020
Figure 17. Europe Dermatology OTC Medications Sales Market Share in Value by Type in 2020
Figure 18. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Type in 2020
Figure 19. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Type in 2020
Figure 20. Latin America Dermatology OTC Medications Sales Market Share in Volume by Type in 2020
Figure 21. Latin America Dermatology OTC Medications Sales Market Share in Value by Type in 2020
Figure 22. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Type in 2020
Figure 23. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Type in 2020
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Sales in 2020
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Medications Revenue in 2020
Figure 26. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 27. Product Picture of Hospital
Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (M Units)
Figure 29. Product Picture of Drug Store
Figure 30. Global Drug Store Sales YoY Growth (2016-2027) & (M Units)
Figure 31. Product Picture of Other
Figure 32. Global Other Sales YoY Growth (2016-2027) & (M Units)
Figure 33. Global Dermatology OTC Medications Sales by Application (2016-2027) & (US$ Million)
Figure 34. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2016-2021)
Figure 35. Global Dermatology OTC Medications Sales Market Share in Value by Application (2016-2021)
Figure 36. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2022-2027)
Figure 37. North America Dermatology OTC Medications Sales Market Share in Volume by Application in 2020
Figure 38. Latin America Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Figure 39. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Application in 2020
Figure 40. Key Raw Materials Price
Figure 41. Dermatology OTC Medications Manufacturing Cost Structure
Figure 42. Dermatology OTC Medications Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Dermatology OTC Medications Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
BayerGSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
